Farther Finance Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Farther Finance Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.67K	Hold	257	–	–	﹤0.01%	4517
2026 Q1	$7.5K	Hold	257	–	–	﹤0.01%	4289
2025 Q4	$6.73K	Buy	257 +77	+43%	+$1.98K	﹤0.01%	4158
2025 Q3	$4.25K	Buy	180 +73	+68%	+$1.61K	﹤0.01%	3842
2025 Q2	$2.19K	Hold	107	–	–	﹤0.01%	3667
2025 Q1	$2.14K	Buy	+107	New	+$2.39K	﹤0.01%	3362

Other funds holding IDNA

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

HWA

HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return

Farther Finance Advisors's IDNA Position: Q2 2026 in Review

Farther Finance Advisors held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q2 2026 at 257 shares worth $8.67K. The position accounts for ﹤0.01% of the portfolio, ranked #4517.

Farther Finance Advisors first reported a position in IDNA in Q1 2025 and has held it in 6 quarters since. 6 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Farther Finance Advisors held 257 shares of iShares Genomics Immunology and Healthcare ETF worth $8.67K as of Q2 2026.
Farther Finance Advisors left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4517 holding.
Farther Finance Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2025 and has held it in 6 quarters since.
6 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.